Vitamin d and non-hodgkin lymphoma risk in adults: A review

Cancer Investigation

Volumn 27, Issue 9, 2009, Pages 942-951

  Kelly, Jennifer L ^a   Friedberg, Jonathan W ^b   Calvi, Laura M ^b   Van Wijngaarden, Edwin ^a   Fisher, Susan G ^a  

^a UNIVERSITY OF ROCHESTER   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Epidemiology; EtiologyEtiology; Lymphoma; Ultraviolet radiation; Vitamin D

Indexed keywords

VITAMIN D;

CANCER RISK; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; ENVIRONMENTAL EXPOSURE; HUMAN; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REVIEW; SUNLIGHT; SYSTEMATIC REVIEW;

ADULT; CALCIFEDIOL; DIETARY SUPPLEMENTS; DIHYDROXYCHOLECALCIFEROLS; EVIDENCE-BASED MEDICINE; HUMANS; LYMPHOMA, NON-HODGKIN; NUTRITION POLICY; RISK ASSESSMENT; RISK FACTORS; SEASONS; SIGNAL TRANSDUCTION; ULTRAVIOLET RAYS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 70350145108     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357900902849632     Document Type: Review

References (91)

1. Ries, L.; Melbert, D.; Krapcho, M.; Mariotto, A.; Miller, B.; Feuer, E.; Clegg, L.; Horner, M.; Howlander, N.; Eisner, M.; Reichman, M.; Edwards, B.; eds. SEER Cancer Statistics Review, 1975- 2004. http://seer.cancer.gov/csr/1973- 2004/. based on November 2006 SEER data submission, posted to the SEER website, 2007. Bethesda, M.D: National Cancer Institute; 2005.
2. Fisher, S.G.; Fisher, R.I. The epidemiology of non-Hodgkin's lymphoma. Oncogene 2004, 23(38), 6524-6534
3. Grulich, A.E.; Vajdic, C.M.; Cozen, W. Altered immunity as a risk factor for non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2007, 16(3), 405-408 (Pubitemid 46548641)
4. Engels, E.A.; Goedert, J.J. Human immunodeficiency virus/acquired immunodeficiency syndrome and cancer: past, present, and future. J Natl Cancer Inst 2005, 97(6), 407-409
5. Baris, D.; Zahm, S.H. Epidemiology of lymphomas. Curr Opin Oncol 2000, 12(5), 383-394
6. Tavani, A.; La Vecchia, C.; Franceschi, S.; Serraino, D.; Carbone, A. Medical history and risk of Hodgkin's and non-Hodgkin's lymphomas. Eur J Cancer Prev 2000, 9(1), 59-64.
7. Alexander, D.D.; Mink, P.J.; Adami, H.O.; Chang, E.T.; Cole, P.; Mandel, J.S.; Trichopoulos, D. The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int J Cancer 2007, 120(Suppl 12), 1-39. (Pubitemid 46732571)
8. Engels, E.A. Infectious agents as causes of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2007, 16(3), 401-404
9. Muller, A.M.; Ihorst, G.; Mertelsmann, R.; Engelhardt, M. Epidemiology of non-Hodgkin's lymphoma (NHL): trends, geographic distribution, and etiology. Ann Hematol 2005, 84(1), 1-12.
10. Thomas, R.K.; Re, D.; Zander, T.; Wolf, J.; Diehl, V. Epidemiology and etiology of Hodgkin's lymphoma. Ann Oncol 2002, 13(Suppl 4), 147-152
11. Adami, H.O.; Hunter, D.; Trichopoulos, D.; editors. Textbook of Cancer Epidemiology. New York: Oxford University Press, Inc.; 2002.
12. Giordano, T.P.; Henderson, L.; Landgren, O.; Chiao, E.Y.; Kramer, J.R.; El-Serag, H.; Engels, E.A. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. Jama 2007, 297(18), 2010-2017
13. Fisher, S.G.; Fisher, R.I. The emerging concept of antigen-driven lymphomas: epidemiology and treatment implications. Curr Opin Oncol 2006, 18(5), 417-424
14. Wang, S.S.; Slager, S.L.; Brennan, P.; Holly, E.A.; De Sanjose, S.; Bernstein, L.; Boffetta, P.; Cerhan, J.R.; Maynadie, M.; Spinelli, J.J.; Chiu, B.C.; Cocco, P.L.; Mensah, F.; Zhang, Y.; Nieters, A.; Dal Maso, L.; Bracci, P.M.; Costantini, A.S.; Vineis, P.; Severson R.K, Roman, E.; Cozen, W.; Weisenburger, D.; Davis, S.; Franceschi, S.; La Vecchia, C.; Foretova, L.; Becker, N.; Staines, A.; Vornanen, M.; Zheng, T.; Hartge, P. Family history of hematopoietic malignancies and risk of non-Hodgkin lymphoma (NHL): a pooled analysis of 10 211 cases and 11 905 controls from the International Lymphoma Epidemiology Consortium (InterLymph). Blood 2007, 109 (8), 3479-3488
15. Mensah, F.K.; Willett, E.V.; Ansell, P.; Adamson, P.J.; Roman, E. Non-Hodgkin's lymphoma and family history of hematologic malignancy. Am J Epidemiol 2007, 165(2), 126-133
16. Longo, D.L. Lymphomas: complexity, not chaos. Curr Opin Oncol 2000, 12(5), 379-382
17. Banks, P. Changes in diagnosis of non-Hodgkin's lymphomas over time. Cancer Res 1992, 52(19), 5453s-5455.
18. Hartge, P.; Devesa, S.S. Quantification of the impact of known risk factors on time trends in non-Hodgkin's lymphoma incidence. Cancer Res 1992, 52(19 Suppl), 5566s-5569s.
19. Cerhan, J.R.; Janney, C.A.; Vachon, C.M.; Habermann, T.M.; Kay, N.E.; Potter, J.D.; Sellers, T.A.; Folsom, A.R. Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective study. Am J Epidemiol 2002, 156(6), 527-535
20. Devesa, S.; Fears, T. Non-Hodgkin's lymphoma time trends: United States and international data. Cancer Res 1992, 52(19), 5432s- 5440.
21. Zheng, T.; Mayne, S.T.; Boyle, P.; Holford, T.R.; Liu,W.L.; Flannery, J. Epidemiology of non-Hodgkin lymphoma in Connecticut. 1935- 1988. Cancer 1992, 70(4), 840-849
22. Adami, J.; Frisch, M.; Yuen, J.; Glimelius, B.; Melbye, M. Evidence of an association between non-Hodgkin's lymphoma and skin cancer. Bmj 1995, 310(6993), 1491-1495
23. Hughes, A.M.; Armstrong, B.K.; Vajdic,C.M.; Turner, J.; Grulich, A.; Fritschi, L.; Milliken, S.; Kaldor, J.; Benke, G.; Kricker, A. Pigmentary characteristics, sun sensitivity and non-Hodgkin lymphoma. Int J Cancer 2004, 110(3), 429-434 (Pubitemid 38649896)
24. Hughes, A.M.; Armstrong, B.K.; Vajdic, C.M.; Turner, J.; Grulich, A.E.; Fritschi, L.; Milliken, S.; Kaldor, J.; Benke, G.; Kricker, A. Sun exposure may protect against non-Hodgkin lymphoma: a casecontrol study. Int J Cancer 2004, 112(5), 865-871
25. Smedby, K.E.; Hjalgrim, H.; Melbye, M.; Torrang, A.; Rostgaard, K.; Munksgaard, L.; Adami, J.; Hansen, M.; Porwit-MacDonald, A.; Jensen, B.A.; Roos, G.; Pedersen, B.B.; Sundstrom, C.; Glimelius, B.; Adami, H.O. Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst 2005, 97(3), 199-209.
26. Weihkopf, T.; Becker, N.; Nieters, A.; Mester, B.; Deeg, E.; Elsner, G.; Blettner, M.; Seidler, A. Sun exposure and malignant lymphoma: a population-based case-control study in Germany. Int J Cancer 2007, 120(11), 2445-2451 (Pubitemid 46642133)
27. Kricker, A.; Armstrong, B.K.; Hughes, A.M.; Goumas, C.; Smedby, K.E.; Zheng, T.; Spinelli, J.J.; De Sanjose, S.; Hartge, P.; Melbye, M.;Willett, E.V.; Becker, N.; Chiu B.C, Cerhan, J.R.; Maynadie, M.; Staines, A.; Cocco, P.; Boffeta, P. Personal sun exposure and risk of non Hodgkin lymphoma: a pooled analysis from the Interlymph Consortium. Int J Cancer 2008, 122(1), 144-154
28. Boffetta, P.; Hel, O.V.; Kricker, A.; Nieters, A.; Sanjose, S.D.; Maynadie, M.; Cocco P.L.; Staines, A.; Becker, N.; Font, R.; Mannetje, A.T.; Goumas, C.; Brennan, P. Exposure to ultraviolet radiation and risk of malignant lymphoma and multiple myeloma- a multicentre European case-control study. Int J Epidemiol 2008, 37(5), 1080-1094.
29. Hartge, P.; Lim, U.; Freedman, D.M.; Colt, J.S.; Cerhan, J.R.; Cozen, W.; Severson, R.K.; Davis, S. Ultraviolet radiation, dietary vitamin, D.; and risk of non-Hodgkin lymphoma (United States). Cancer Causes Control 2006, 17(8), 1045-1052
30. Soni, L.K.; Hou, L.; Gapstur, S.M.; Evens, A.M.; Weisenburger, D.D.; Chiu, B.C. Sun exposure and non-Hodgkin lymphoma: A population-based, case-control study. Eur J Cancer 2007, 43(16), 2388-2395
31. Zhang, Y.; Holford, T.R.; Leaderer, B.; Boyle, P.; Zhu, Y.; Wang, R.; Zou, K.; Zhang, B.; Wise, J.P.; Sr., Qin, Q.; Kilfoy, B.; Han, J.; Zheng, T. Ultraviolet Radiation Exposure and Risk of Non- Hodgkin's Lymphoma. Am J Epidemiol 2007, 165(11), 1255-1264
32. Armstrong, B.K.; Kricker, A. Sun Exposure and Non-Hodgkin Lymphoma. Cancer Epidemiol Biomarkers Prev 2007, 16(3), 396-400.
33. Holick, M.F. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004, 80(6 Suppl), 1678s-88S.
34. Calvo, M.S.; Whiting, S.J.; Barton, C.N. Vitamin D fortification in the United States and Canada: current status and data needs. Am J Clin Nutr 2004, 80(6 Suppl), 1710s-6S.
35. Grant, W.B. Ecologic studies of solar UV-B radiation and cancer mortality rates. Recent Results Cancer Res 2003, 164, 371-377
36. Grant, W.B. Health benefits of solar UV-B radiation through the production of vitamin D. Comment and response. Photochem Photobiol Sci 2003, 2(12), 1307-8; discussion 1308-1310
37. Giovannucci, E. The epidemiology of vitamin D and cancer incidence and mortality: A review (United States). Cancer Causes Control 2005, 16(2), 83-95.
38. Schwartz, G.G.; Skinner, H.G. Vitamin D status and cancer: new insights. Curr Opin Clin Nutr Metab Care 2007, 10(1), 6-11.
39. Egan, K.M.; Sosman, J.A.; Blot, W.J. Sunlight and reduced risk of cancer: is the real story vitamin D? J Natl Cancer Inst 2005, 97 (3), 161-163
40. Holick, M.F. Vitamin D: A millenium perspective. J Cell Biochem 2003, 88(2), 296-307.
41. Banerjee, P.; Chatterjee, M. Antiproliferative role of vitamin D and its analogs-a brief overview. Mol Cell Biochem 2003, 253 (1-2), 247-254
42. Whiting, S.J.; Calvo, M.S. Vitamin D and cancer symposium: Dietary recommendations to meet both endocrine and autocrine needs of Vitamin D. J Steroid Biochem Mol Biol 2005, 97 (1-2), 7-12.
43. Hickish, T.; Cunningham, D.; Colston, K.; Millar, B.C.; Sandle, J.; Mackay, A.G.; Soukop, M.; Sloane, J. The effect of 1,25- dihydroxyvitamin D3 on lymphoma cell lines and expression of vitamin D receptor in lymphoma. Br J Cancer 1993, 68(4), 668-672
44. DeLuca, H.F. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004, 80(6 Suppl), 1689s-96S.
45. Holick, M.F. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004, 79(3), 362-371
46. Mathieu, C.; van Etten, E.; Decallonne, B.; Guilietti, A.; Gysemans, C.; Bouillon, R, Overbergh, L. Vitamin D and 1,25-dihydroxyvitamin D3 as modulators in the immune system. J Steroid Biochem Mol Biol 2004, 89-90 (1-5), 449-452
47. van Etten, E.; Decallonne, B.; Mathieu, C. 1,25- dihydroxycholecalciferol: endocrinology meets the immune system. Proc Nutr Soc 2002, 61(3), 375-380
48. Raina, V.; Cunningham, D.; Gilchrist, N.; Soukop, M. Alfacalcidol is a nontoxic, effective treatment of follicular small-cleaved cell lymphoma. Br J Cancer 1991, 63(3), 463-465
49. Potter, M. Pathogenetic mechanisms in B-cell non-Hodgkin's lymphomas in humans. Cancer Res 1992, 52 (19 Suppl), 5522s-5528s.
50. Reginster, J.Y. The high prevalence of inadequate serum vitamin D levels and implications for bone health. Curr Med Res Opin 2005, 21(4), 579-586
51. Bohnsack, B.L.; Hirschi, K.K. Nutrient regulation of cell cycle progression. Annu Rev Nutr 2004, 24, 433-453
52. Bai, M.; Vlachonikolis, J.; Agnantis, N.J.; Tsanou, E.; Dimou, S.; Nicolaides, C.; Stefanaki, S.; Pavlidis, N.; Kanavaros, P. Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas. Mod Pathol 2001, 14(11), 1105-1113
53. Sherr, C.J. Cancer cell cycles. Science 1996, 274(5293), 1672-1677
54. Holick, M.F. Vitamin D deficiency. N Engl J Med 2007, 357 (3), 266-281
55. Chang, E.T.; Balter, K.M.; Torrang, A.; Smedby, K.E.; Melbye, M.; Sundstrom, C.; Glimelius, B.; Adami, H.O. Nutrient intake and risk of non-Hodgkin's lymphoma. Am J Epidemiol 2006, 164(12), 1222-1232
56. Polesel, J.; Talamini, R.; Montella, M.; Parpinel, M.; Dal Maso, L.; Crispo, A.; Crovatto, M.; Spina, M.; La Vecchia, C.; Franceschi, S. Linoleic acid, vitamin D and other nutrient intakes in the risk of non-Hodgkin lymphoma: an Italian case-control study. Ann Oncol 2006, 17(4), 713-718
57. Purdue, M.P.; Hartge, P.; Davis, S.; Cerhan, J.R.; Colt, J.S.; Cozen, W.; Severson, R.K.; Li, Y.; Chanock, S.J.; Rothman, N.; Wang, S.S. Sun exposure, vitamin D receptor gene polymorphisms and risk of non-Hodgkin lymphoma. Cancer Causes Control 2007, 18 (9), 989-999 (Pubitemid 47237960)
58. Giovannucci, E.; Liu, Y.; Rimm, E.B.; Hollis, B.W.; Fuchs, C.S.; Stampfer, M.J.; Willett, W.C. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006, 98(7), 451-459
59. Freedman, D.M.; Looker, A.C.; Chang, S.C.; Graubard, B.I. Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst 2007, 99 (21), 1594-1602
60. Lim, U.; Freedman, D.M.; Hollis, B.W.; Horst, R.L.; Purdue, M.P.; Chatterjee, N.; Weinstein, S.J.; Morton, L.M.; Schatzkin, A.; Virtamo, J.; Linet, M.S.; Hartge, P.; Albanes, D. A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers. Int J Cancer 2009, 124(4), 979-986
61. Willett, W.C. Nutritional Epidemiology. 2nd ed. New York and Oxford: Oxford University Press; 1998.
62. Gordis, L. Epidemiology. 4th ed. Philadelphia: W.B. Saunders Company; 2009.
63. Lu, Z.; Chen, T.C.; Zhang, A.; Persons, K.S.; Kohn, N.; Berkowitz, R.; Martinello, S.; Holick, M.F. An evaluation of the vitamin D3 content in fish: Is the vitamin D content adequate to satisfy the dietary requirement for vitamin D? J Steroid Biochem Mol Biol 2007, 103(3-5), 642-644
64. Tanner, J.T.; Smith, J.; Defibaugh, P.; Angyal, G.; Villalobos, M.; Bueno, M.P.; McGarrahan, E.T.; Wehr, H.M.; Muniz, J.F.; Hollis, B.W.; Koh, Y.; Reich, P.; Simpson, K.L. Survey of vitamin content of fortified milk. J Assoc Off Anal Chem 1988, 71 (3), 607-610
65. Holick, M.F.; Shao, Q.; Liu, W.W.; Chen, T.C. The vitamin D content of fortified milk and infant formula. N Engl J Med 1992, 326(18), 1178-1181
66. Faulkner, H.; Hussein, A.; Foran, M.; Szijarto, L. A survey of vitamin A and D contents of fortified fluid milk in Ontario. J Dairy Sci 2000, 83(6), 1210-1216
67. Murphy, S.C.; Whited, L.J.; Rosenberry, L.C.; Hammond, B.H.; Bandler, D.K.; Boor, K.J. Fluid milk vitamin fortification compliance in New York State. J Dairy Sci 2001, 84(12), 2813-2820
68. Skibola, C.F. Obesity, diet and risk of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2007, 16(3), 392-395
69. Cross, A.J.; Lim, U. The role of dietary factors in the epidemiology of non-Hodgkin's lymphoma. Leuk Lymphoma 2006, 47 (12), 2477-2487
70. Rangarajan, A.; Hong, S.J.; Gifford, A.; Weinberg, R.A. Speciesand cell type-specific requirements for cellular transformation. Cancer Cell 2004, 6(2), 171-183
71. Weiss, R.A. Multistage carcinogenesis. Br J Cancer 2004, 91 (12), 1981-1982
72. Rothman, K.J.; Poole, C. Causation and causal inference. In: Fraumeni, Sa.; editor. Cancer Epidemiology and Prevention. 2nd ed. New York: Oxford University Press; 1996.
73. Holick, M.F. Evolution and function of vitamin D. Recent Results Cancer Res 2003, 164, 3-28.
74. Holick, M.F. Vitamin D Status: Measurement, Interpretation, and Clinical Application. Ann Epidemiol 2008, 19(2), 73-78
75. Wild, C.P.; Andersson, C.; O'Brien, N.M.; Wilson, L.; Woods, J.A. A critical evaluation of the application of biomarkers in epidemiological studies on diet and health. Br J Nutr 2001, 86 (Suppl 1), S37-53.
76. Vieth, R.; Bischoff-Ferrari, H.; Boucher, B.J.; Dawson-Hughes, B.; Garland, C.F.; Heaney, R.P.; Holick, M.F.; Hollis, B.W.; Lamberg- Allardt, C.; McGrath, J.J.; Norman, A.W.; Scragg, R.; Whiting, S.J.; Willett, W.C.; Zittermann, A. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr 2007, 85 (3), 649-650
77. Holick, M.F.; Chen, T.C. Vitamin D deficiency: a worldwide problem with health consequences. AmJ Clin Nutr 2008, 87(4), 1080s-6S.
78. Giovannucci, E. Strengths and limitations of current epidemiologic studies: vitamin D as a modifier of colon and prostate cancer risk. Nutr Rev 2007, 65(8 Pt 2):S77-9.
79. Garland, C.F.; Grant, W.B.; Mohr, S.B.; Gorham, E.D.; Garland, F.C. What is the dose-response relationship between vitamin D and cancer risk? Nutr Rev 2007, 65(8 Pt 2):S91-5.
80. Ansell, S.M.; Armitage, J. Non-Hodgkin lymphoma: diagnosis and treatment. Mayo Clin Proc 2005, 80(8), 1087-1097
81. Cheson, B.D. What is new in lymphoma? CA Cancer J Clin 2004, 54(5), 260-272
82. Fisher, R.I. Overview of non-Hodgkin's lymphoma: biology, staging, and treatment. Semin Oncol 2003, 30(2 Suppl 4), 3-9.
83. Evens, A.M.; Chiu, B.C. The Challenges of Epidemiologic Research in Non-Hodgkin Lymphoma. JAMA 2008, 300 (17), 2059-2061.
84. Townsend, K.; Evans, K.N.; Campbell, M.J.; Colston, K.W.; Adams, J.S.; Hewison, M. Biological actions of extra-renal 25-hydroxyvitamin D-1alpha-hydroxylase and implications for chemoprevention and treatment. J Steroid Biochem Mol Biol 2005, 97(1-2), 103-109
85. Abbas, S.; Linseisen, J.; Slanger, T.; Kropp, S.; Mutschelknauss, E.J.; Flesch-Janys, D.; Chang-Claude, J. The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin d status. Cancer Epidemiol Biomarkers Prev 2008, 17(6), 1339-1343
86. Purdue, M.P.; Lan, Q.; Kricker, A.; Vajdic, C.M.; Rothman, N.; Armstrong, B.K. Vitamin D receptor gene polymorphisms and risk of non-Hodgkin's lymphoma. Haematologica 2007, 92(8), 1145-1146 (Pubitemid 350144227)
87. Raiten, D.J.; Picciano, M.F. Vitamin D and health in the 21st century: bone and beyond. Executive summary. Am J Clin Nutr 2004, 80(6 Suppl), 1673s-7S.
88. Cantorna M.T. Vitamin, D and autoimmunity: is vitamin D status an environmental factor affecting autoimmune disease prevalence? Proc Soc Exp Biol Med 2000, 223(3), 230-233
89. Cantorna, M.T.; Mahon, B.D. Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood) 2004, 229(11), 1136-1142
90. Munger, K.L.; Levin, L.I.; Hollis, B.W.; Howard, N.S.; Ascherio, A. Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis. JAMA 2006, 296(23), 2832-2838. (Pubitemid 44969183)
91. Harris, D.M.; Go, V.L. Vitamin D and colon carcinogenesis. J Nutr 2004, 134(12 Suppl), 3463s-3471S.